Advanced Medical Solutions Grp PLC Director/PDMR and PCA Shareholding (4167B)

TIDMAMS

RNS Number : 4167B

Advanced Medical Solutions Grp PLC

03 April 2017

 
   3 April 2017 
 

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that it was notified on 29 March 2017 that Ingrid Meredith, the wife of Chris Meredith who is a Director and PDMR, had transferred 1,009,268 Ordinary Shares of 5p held in her name to Platform Securities Nominees Limited at nil consideration on 29 March 2017. The beneficial ownership of the shares remains unchanged.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  -------------------------------------------------------------- 
 a)   Name: Ingrid Meredith (the wife of Chris 
       Meredith) 
---  -------------------------------------------------------------- 
 2.   Reason for the notification 
---  -------------------------------------------------------------- 
 a)   Position/status: PCA of a Director/PDMR 
---  -------------------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  -------------------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  -------------------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  -------------------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  -------------------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  -------------------------------------------------------------- 
 b)      Nature of the transaction: 
           *    Transfer of 1,009,268 Ordinary Shares of 5p held by 
                Ingrid Meredith in her own name into the name of 
                Platform Securities Nominees Limited 
---  -------------------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)             Volume(s) 
       -------------------  ---------- 
        Nil consideration    1,009,268 
       -------------------  ---------- 
---  -------------------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: n/a 
       Aggregated price: n/a 
---  -------------------------------------------------------------- 
 e)   Date of the transaction: 29/03/2017 
---  -------------------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  -------------------------------------------------------------- 
 

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                Tel: +44 (0) 
  plc                                             1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications              Tel: +44 (0) 
                                                 20 3709 5700 
 Mary-Jane Elliott / Jonathan         [e-mail] 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank PLC (NOMAD & Broker)              Tel: +44 (0) 
                                                 20 7597 5970 
 Daniel Adams / Patrick Robb 
 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFISSAIVIID

(END) Dow Jones Newswires

April 03, 2017 10:12 ET (14:12 GMT)